Literature DB >> 20451923

HIF-1α and VEGF are associated with disease progression in esophageal carcinoma.

Heikki Takala1, Juha Saarnio, Heikki Wiik, Pasi Ohtonen, Ylermi Soini.   

Abstract

BACKGROUND: Hypoxia inducible factor-1alpha (HIF-1α) is a transcription factor that regulates the transcription of genes associated with cell proliferation and angiogenesis. The purpose of this study is to clarify the correlation of HIF-1α protein expression with vascular endothelial growth factor (VEGF) and inducible (iNOS), endothelial (eNOS), and neuronal nitric oxide synthase (nNOS) expression in esophageal tumors. Additionally, vascular density in tumor tissue was assessed.
MATERIALS AND METHODS: Eighty-eight esophageal carcinomas were analyzed by immunohistochemistry in paraffin embedded sections.
RESULTS: HIF-1α immunoreactivity was seen in 71.2 % of the tumors. Squamous cell carcinomas expressed more often HIF-1α than adenocarcinomas (P = 0.009). HIF-1α immunoreactivity was associated with iNOS (P = 0.049), and iNOS positivity was also more commonly seen in squamous cell carcinomas than adenocarcinomas (P = 0.016). VEGF immunoreaction tended to associate with HIF-1α (P = 0.073) and iNOS (P = 0.08). ENOS did not associate with HIF-1α, but tended to associate with VEGF (P = 0.072). T1-T2 tumors were more often VEGF negative than T3-T4 tumors (P = 0.063). In the subgroup of 78 operatively treated ECs patients with HIF-1α positivity (> +) had more often distant metastases (P = 0.036). There was no association between iNOS, eNOS, nNOS, or VEGF, and microvessel density in tumor tissue, tumor marginal zone, or in peripheral tissue.
CONCLUSIONS: These results show that there is a link in expression between HIF-1α, iNOS, (eNOS), and VEGF in esophageal cancer. This is in line with the fact of HIF-1α's function as a transcriptional factor for these angiogenic factors. Results also show that squamous cell and adenocarcinomas differ in their expression of HIF-1α and iNOS. VEGF appear to have association with depth of invasion in esophageal carcinomas. In our material HIF-1α positivity was associated with distant metastases, but not with patient survival.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20451923     DOI: 10.1016/j.jss.2009.11.725

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  7 in total

1.  Clinical trial of thalidomide combined with radiotherapy in patients with esophageal cancer.

Authors:  Jing-Ping Yu; Su-Ping Sun; Zhi-Qiang Sun; Xin-Chu Ni; Jian Wang; Yi Li; Li-Jun Hu; Dong-Qing Li
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

Review 2.  Inducible Nitric Oxide Synthase in the Carcinogenesis of Gastrointestinal Cancers.

Authors:  Graciele Almeida de Oliveira; Robert Y S Cheng; Lisa A Ridnour; Debashree Basudhar; Veena Somasundaram; Daniel W McVicar; Hugo Pequeno Monteiro; David A Wink
Journal:  Antioxid Redox Signal       Date:  2016-10-31       Impact factor: 8.401

3.  Low expression of LncRNA-CAF attributed to the high expression of HIF1A in esophageal squamous cell carcinoma and gastric cancer patients.

Authors:  Shabbou Bahramian; Reza Sahebi; Zahra Roohinejad; Encieh Delshad; Naeme Javid; Abolfazl Amini; Amirnader Emami Razavi; Mohammad Shafiee; Fatemeh T Shamsabadi
Journal:  Mol Biol Rep       Date:  2022-01-18       Impact factor: 2.316

4.  Endothelial hypoxic metabolism in carcinogenesis and dissemination: HIF-A isoforms are a NO metastatic phenomenon.

Authors:  Cristina Branco-Price; Colin E Evans; Randall S Johnson
Journal:  Oncotarget       Date:  2013-12

5.  A new key player in VEGF-dependent angiogenesis in human hepatocellular carcinoma: dimethylarginine dimethylaminohydrolase 1.

Authors:  Nikki Buijs; J Efraim Oosterink; Morgan Jessup; Henk Schierbeek; Donna B Stolz; Alexander P Houdijk; David A Geller; Paul A van Leeuwen
Journal:  Angiogenesis       Date:  2017-07-24       Impact factor: 9.596

6.  miR-199a-5p inhibits proliferation and induces apoptosis in hemangioma cells through targeting HIF1A.

Authors:  Yang Wang; Yu-Xin Dai; Shu-Qing Wang; Ming-Ke Qiu; Zhi-Wei Quan; Ying-Bin Liu; Jing-Min Ou
Journal:  Int J Immunopathol Pharmacol       Date:  2017-12-22       Impact factor: 3.219

7.  Expression of HIF-1α and VEGF in feline mammary gland carcinomas: association with pathological characteristics and clinical outcomes.

Authors:  Bo Chen; Susanne Je-Han Lin; Wen-Ta Li; Hui-Wen Chang; Victor Fei Pang; Pei-Yi Chu; Chin-Cheng Lee; Hiroyuki Nakayama; Ching-Ho Wu; Chian-Ren Jeng
Journal:  BMC Vet Res       Date:  2020-05-06       Impact factor: 2.741

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.